Open Government Portal

Found 10 records similar to Least-developed countries eligible to import under Canada's Access to Medicines Regime

Federal

It presents WTO-Member Countries and Non-WTO Member Countries Eligible to Import Under the Regime.

Last Updated: Sep. 17, 2020
Date Published: Mar. 17, 2017
Organization: Health Canada
Formats: HTML
Keywords:  Canada's Access to Medicines Regime, WTO-member countries, non-WTO member countries, countries eligible to import under the Regime.
Federal

Canada's Access to Medicines Regime provides a way for the world's developing and least-developed countries to import high-quality drugs and medical devices at a lower cost to treat the diseases that bring suffering to their citizens.

Last Updated: Sep. 17, 2020
Date Published: Apr. 25, 2017
Organization: Health Canada
Formats: HTML
Keywords:  Canada's Access to Medicines Regime, developing and least-developed countries, import high-quality drugs and medical devices, a lower cost drug and medical devices.
Federal

It presents WTO-Member Countries Eligible to Import Under the Regime

Last Updated: Sep. 17, 2020
Date Published: Mar. 17, 2017
Organization: Health Canada
Formats: HTML
Keywords:  Canada's Access to Medicines Regime, WTO-member countries, countries eligible to import under the Regime.
Federal

Canada's Access to Medicines Regime is intended to address public health problems afflicting many developing and least-developed countries, especially those resulting from HIV/AIDS, tuberculosis, malaria and other diseases.

Last Updated: Sep. 17, 2020
Date Published: Mar. 29, 2017
Organization: Health Canada
Formats: HTML
Keywords:  Canada's Access to Medicines Regime, World Trade Organization, negotiations between the Government of Canada, the private sector and non-governmental organizations, public health problems.
Federal

Canada's Access to Medicines Regime provides a framework within which eligible countries can import less expensive generic versions of patented drugs and medical devices.

Last Updated: Sep. 17, 2020
Date Published: Mar. 23, 2017
Organization: Health Canada
Formats: HTML
Keywords:  Canada's Access to Medicines Regime, developing and least-developed countries, import less expensive generic drugs, patented drugs and medical devices.
Federal

Countries with insufficient or no manufacturing capacity in the pharmaceutical sector can benefit from participating in Canada's Access to Medicines Regime. Under the Regime, eligible countries can import less expensive, generic versions of patented products manufactured in Canada.

Last Updated: Sep. 17, 2020
Date Published: Mar. 29, 2017
Organization: Health Canada
Formats: HTML
Keywords:  Country access, Canada's Access to Medicines Regime, insufficient or no manufacturing capacity in the pharmaceutical sector, import a lower cost drug and medical devices.
Federal

In August 2003, negotiations among World Trade Organization (WTO) members resulted in a landmark decision to waive two licensing provisions of the WTO Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS) that appeared to prevent the export of generic drugs and medical devices to developing countries faced with public health problems.

Last Updated: Sep. 17, 2020
Date Published: Mar. 28, 2017
Organization: Health Canada
Formats: HTML
Keywords:  Canada's Access to Medicines Regime, World Trade Organization, waive licensing provisions, WTO Agreement, Intellectual Property Rights, developing and least-developed countries, import high-quality drugs and medical devices
Federal

To participate in the Regime, an eligible importing country must declare that it has insufficient or no pharmaceutical manufacturing capacity in relation to the specific product it is requesting. It is up to each country to determine for itself the level of its manufacturing capacity.

Last Updated: Sep. 17, 2020
Date Published: Mar. 29, 2017
Organization: Health Canada
Formats: HTML
Keywords:  Canada's Access to Medicines Regime, manufacturing capacity, eligible importing country, insufficient or no pharmaceutical manufacturing capacity.
Federal

This process map provides a visual overview of the steps that need to be followed by a pharmaceutical company that is preparing to submit an application for a compulsory licence under Canada's Access to Medicines Regime.

Last Updated: Sep. 17, 2020
Date Published: Apr. 28, 2017
Organization: Health Canada
Formats: HTML
Keywords:  Process map, application under Canada's Access to Medicines Regime, application for a compulsory licence.
Federal

This process map provides a visual overview of the steps that need to be followed by a pharmaceutical company to meet the terms and conditions of a compulsory licence under Canada's Access to Medicines Regime.

Last Updated: Sep. 17, 2020
Date Published: Apr. 28, 2017
Organization: Health Canada
Formats: HTML
Keywords:  Process map, an application under Canada's Access to Medicines Regime, terms and conditions of a compulsory licence.
Date modified: